BioLogo was acquired in 2018 by Nordic Mubio. They offer a wide range of antibodies and detection systems for all types of biological and medical research. The main focus of their product line is on immunohistochemistry (IHC). For this area, they select antibodies with a high level of specificity and avidity which can be easily used in paraffin sections.
Antibodies against extracellular matrix proteins (ECM) - collagen types I to IX, elastin, fibronectin, laminin and other antibodies against advanced glycation end products
primary antibody, secondary antibody, extracellular matrix (ECM), collagen type I-IX, high specificity, high avidity